Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Times Interest Earned (2016 - 2025)

Ironwood Pharmaceuticals' Times Interest Earned history spans 16 years, with the latest figure at -$9.76 for Q4 2025.

  • For Q4 2025, Times Interest Earned fell 376.36% year-over-year to -$9.76; the TTM value through Dec 2025 reached $0.45, down 84.07%, while the annual FY2025 figure was $0.45, 84.07% down from the prior year.
  • Times Interest Earned for Q4 2025 was -$9.76 at Ironwood Pharmaceuticals, down from $8.95 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $93.07 in Q4 2023 and bottomed at -$588.66 in Q2 2023.
  • The 5-year median for Times Interest Earned is $6.54 (2021), against an average of -$13.53.
  • The largest annual shift saw Times Interest Earned surged 529.41% in 2022 before it crashed 2434.34% in 2023.
  • A 5-year view of Times Interest Earned shows it stood at $7.12 in 2021, then soared by 529.41% to $44.8 in 2022, then skyrocketed by 107.75% to $93.07 in 2023, then tumbled by 96.2% to $3.53 in 2024, then crashed by 376.36% to -$9.76 in 2025.
  • Per Business Quant, the three most recent readings for IRWD's Times Interest Earned are -$9.76 (Q4 2025), $8.95 (Q3 2025), and $5.42 (Q2 2025).